Event Recordings

Day 1  |  Day 2

Day 2: Tuesday, April 25, 2023

Session VII: Drug Approval Process

Moderator: Mathai Mammen, MD, PhD

Transitioning Gene Therapy to Main Stream Therapy

Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research (CBER), FDA

Disparities in Clinical Trial Enrollment

What will it take to close the gap?

Patrizia Cavazzoni, MD
Director, Center for Drug Evaluation and Research FDA

The Inflation Reduction Act

Some Implications for Drug Innovation

Mark McClellan, MD, PhD, MPA
Director and Robert J. Margolis, MD, Professor of Business, Medicine and Policy, Duke-Margolis Center for Health Policy

Advancing Alternative Methods in Regulatory Science

Namandjé Bumpus, PhD
Chief Scientist, FDA

Session VII: Panel Discussion

Session VIII: Drug Development III

Moderator: Levi Garraway, MD, PhD

Connecting the Dots in R&D

Frank Nestle, MD
Global Head of Research & CSO, Sanofi

Improving Drug Discovery Success Rates through Genetics and Genomics

John Lepore, MD
Senior Vice President of Research, GSK

Targeting Strategies to Enhance Therapeutic Efficacy

Fiona Marshall, PhD
President, Novartis Institutes for BioMedical Research

Our Relentless Pursuit of Transformational Medicines for Patients

A Janssen R&D Perspective

John Reed, MD, PhD
Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson

Cardiac Myosin Modulation for Heart Failure

Fady Malik, MD, PhD
Executive Vice President of R&D, Cytokinetics

Session VIII: Panel Discussion

Session IX: Making Transitions with Biopharma Discussion

Moderator: Sandra Horning, MD


Daniel O’Day, MBA
Chairman and CEO, Gilead Sciences, Inc.

Merdad Parsey, MD, PhD
Chief Medical Officer, Gilead Sciences

Session X: Foundations Role in Drug Development

Moderator: Hannah Valantine, MD

Advancing Cell and Gene Therapies

It’s a Partnership

Maria Millan, MD
President and CEO, CIRM

A New Breed of Cancer Non-Profit

Driving Research and Accelerating Cures

Louis DeGennaro, PhD
President and CEO, The Leukemia & Lymphoma Society

Pushing the Boundaries of Science with Cutting Edge Technology and Research Innovation

Nancy Brown
CEO, American Heart Association

Session X: Panel Discussion

Session XI: Nobel Laureate Panel Discussion

Moderator: Marc Tessier-Lavigne, PhD


Carolyn Bertozzi, PhD
Nobel Laureate 2022; Baker Family Director of Stanford ChEM-H

Jennifer Doudna, PhD
Nobel Laureate 2020; Professor in Biomedical and Health Sciences, UC Berkeley

Brian Kobilka, MD
Nobel Laureate 2012; Helene Irwin Fagan Chair of Cardiology, Professor, Department of Molecular and Cellular Physiology, Stanford University

Roger Kornberg, PhD
Nobel Laureate 2006; Mrs. George A. Winzer Professor of Medicine, Stanford University